Gainers
Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) shares jumped 110% to $13.93 after the company announced initial data from the pivotal FIREFLY-1 trial of tovorafenib in relapsed pediatric low-grade glioma showed an overall response rate of 64%.
Cumulus Media Set to Join Russell 3000® Index
ATLANTA, June 06, 2022 (GLOBE NEWSWIRE) -- Cumulus Media Inc. (NASDAQ:CMLS) (the "Company" or "Cumulus") today announced it is set to join the
On Monday, shares of Cumulus Media Inc. (NASDAQ: CMLS) experienced volatile short activity. After the activity, the stock price went up at 3.35% to $13.25.
The overall sentiment for CMLS has been Bullish.
Companies Reporting Before The Bell
• Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.